Skip to main content

Daxor Corporation (DXR)

NYSEAMERICAN: DXR · IEX Real-Time Price · USD
10.59 -0.41 (-3.73%)
Oct 22, 2021 4:00 PM EDT - Market closed
Market Cap43.40M
Revenue (ttm)271,145
Net Income (ttm)n/a
Shares Out4.03M
EPS (ttm)0.07
PE Ratio145.07
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,418
Open11.00
Previous Close11.00
Day's Range10.59 - 10.88
52-Week Range8.58 - 17.58
Beta-1.16
AnalystsBuy
Price Target22.00 (+107.7%)
Est. Earnings Daten/a

About DXR

Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hypo...

IndustryHealth Care Equipment & Supplies
Founded1970
CountryUnited States
Stock ExchangeNYSEAMERICAN
Ticker SymbolDXR
Full Company Profile

Analyst Forecast

According to one analyst, the rating for Daxor stock is "Buy" and the 12-month stock price forecast is 22.00.

Price Target
$22.00
(107.74% upside)
Analyst Consensus: Buy

News

Daxor Corporation Receives $200K Matching Fund Award from Launch Tennessee

The SBIR/STTR Matching Fund Grant Will Advance the Company's Innovation and Commercialization Efforts, and Job Creation

3 weeks ago - GlobeNewsWire

Daxor Corporation Presents New Data Validating the Benefit of the BVA-100® Blood Test for Heart Failure Patients at K...

Data from Three New Studies and Two Ongoing Trials Presented at the Heart Failure Society of America Annual Scientific Meeting 2021 Data Highlight Importance of Blood Volume Analysis in Providing Approp...

1 month ago - GlobeNewsWire

Daxor Corporation to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference

Oak Ridge, TN, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Daxor Corpor a tion (NYSE:DXR), the global leader in blood volume measurement technology, today announces that President and Chief Executive Officer Mic...

1 month ago - GlobeNewsWire

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

Oak Ridge, TN, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today it issued a corporate update in a Letter to Sha...

1 month ago - GlobeNewsWire

Daxor Corporation Reports a 26.5 Percent Rise in Diagnostic Sales Revenue in Form N-CSR Filing for the Six Months End...

Company forecasts further increase in sales driven by new distributor agreements

1 month ago - GlobeNewsWire

Daxor's Blood Volume (BVA-100®) Diagnostic Demonstrates Clinical Utility In Critically-Ill COVID-19 Patients In Newly...

Data Led to Multi-Center Study In Progress At Three Leading Hospitals

2 months ago - GlobeNewsWire

DAXOR CORPORATION ANNOUNCES NON-GOVERNMENT DISTRIBUTION AGREEMENT WITH CONCORDANCE® HEALTHCARE SOLUTIONS

NEW YORK, July 22, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, announces today that it has signed a non-government distribution ...

3 months ago - GlobeNewsWire

American College of Cardiology (ACC) Features Expert Analysis on the Importance of Addressing Anemia With Blood Volum...

Cites Evidence from Studies Utilizing Daxor's BVA-100® Blood Volume Analyzer

3 months ago - GlobeNewsWire

Daxor Corporation to Present at the Summer Solstice - Best Ideas from the Buy Side Conference on June 2, 2021

NEW YORK, May 28, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that Michael Feldschuh, Daxor's President and Chief Ex...

4 months ago - GlobeNewsWire

Daxor Corporation Announces 61% Increase in Q1 2021 Sales Revenue and Further Acquisitions of its BVA-100® Blood Volu...

NEW YORK, NY, May 13, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announced a Q1 2021 increase in revenue of 61% in its op...

5 months ago - GlobeNewsWire

Newly Published Study Demonstrates Clinical Utility of Daxor's Blood Volume (BVA-100®) Diagnostic in the Assessment o...

NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces new data demonstrating the clinical utility of t...

5 months ago - GlobeNewsWire

Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference

NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, announces today that President and CEO Michael Feldschuh will presen...

7 months ago - GlobeNewsWire

DAXOR CORPORATION ANNOUNCES NOVEL FLUORESCENT TRACER AND PHASE-TWO US AIR FORCE CONTRACT AWARD OF $750,000 FOR POINT-...

BREAKTHROUGH PATENT-PENDING TRACER DEVELOPED FOR BROAD USE

7 months ago - GlobeNewsWire

Daxor Corporation Announces $0.48 Per Share NAV Increase and Files Annual Report for Fiscal 2020

Revenues of Operating Division Increase by 50.4%

7 months ago - GlobeNewsWire

DAXOR CORPORATION AWARDED GRANT FROM THE CENTER FOR ADVANCING POINT OF CARE TECHNOLOGIES (CAPCAT) TO DEVELOP A POINT-...

NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, announces today that it has been awarded a grant from the Center ...

8 months ago - GlobeNewsWire

New Research Demonstrates the Clinical Utility with Daxor's Blood Volume Analyzer (BVA-100®) in Critical Care

Study Presented At the Society for Critical Care Medicine (SCCM) 50th Congress

8 months ago - GlobeNewsWire

DAXOR ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH L1 ENTERPRISES GOVERNMENT DISTRIBUTOR

NEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology (organized as an investment company with fully-owned innovative me...

9 months ago - GlobeNewsWire

Daxor to Present at the Inaugural H.C. Wainwright BioConnect 2021 Conference

NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology (organized as an investment company with fully-owned innovative me...

9 months ago - GlobeNewsWire

Daxor Corporation Announces Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Thr...

NEW YORK, NY, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume meas...

10 months ago - GlobeNewsWire

Daxor Corporation to Present at the 13th Annual LD Micro Main Event 2020

NEW YORK, NY, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume meas...

10 months ago - GlobeNewsWire

THIRD HOSPITAL JOINS MULTICENTER COVID-19 BVA-100® BLOOD TEST STUDY

NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurem...

11 months ago - GlobeNewsWire

OREGON HEALTH & SCIENCE UNIVERSITY JOINS MULTICENTER COVID-19 BVA-100® STUDY

COVID-19 Investigation Continues at OHSU to Study Hospitalized Patients Utilizing Daxor's Blood Volume Analysis Technology

11 months ago - GlobeNewsWire

Daxor to Present at the 2020 MicroCap Rodeo Best Ideas Bowl

NEW YORK, NY, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume meas...

1 year ago - GlobeNewsWire

New Research Shows Daxor’s BVA-100® Blood Test Provides Unique Benefit in Detecting Anemia and Heart Failure Risk, Pr...

NEW YORK, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurem...

1 year ago - GlobeNewsWire